Overview

Behavioral Health Software Market is forecasted to value over USD 3.2 billion by 2027 end and register a CAGR of 15% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Behavioral Health Software Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Behavioral Health Software Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Behavioral Health Software Market are    
• CERNER CORPORATION    
• EPIC SYSTEMS  
• NETSMART TECHNOLOGIES    
• NEXTGEN HEALTHCARE  
• ALLSCRIPTS  
• CUREMD
• MEDIWARE
• KAREO
• EMIS HEALTH
• THE ECHO GROUP
(Note: The list of the major players will be updated with the latest market scenario and trends)

Behavioral Health Software Market Segmentation:

By Component

• Support Services
• Software
• Integrated Software 
• Standalone Software

By Delivery Model

• Subscription Models
• Ownership Models

By Functionality

• Clinical Functionality
• Electronic Health Records (EHR) 
• Clinical Decision Support (CDS) 
• Care Plans/Health Management 
• E-Prescribing 
• Telehealth
• Administrative Functionality
• Patient/Client Scheduling 
• Document/Image Management 
• Case Management 
• Business Intelligence (BI) 
• Workforce Management
• Financial Functionality
• Revenue Cycle Management 
• Managed Care 
• Accounts Payable/General Ledger 
• Payroll

By End User

• Providers         
• Community Clinics 
• Hospitals 
• Private Practices 
• Payers 
• Patients           

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Behavioral Health Software Market by component, by delivery, by functionality, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Behavioral Health Software Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Behavioral Health Software Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Behavioral Health Software Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Behavioral Health Software Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global Behavioral Health Software Market, By Component Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1. Support Services
        7.2. Software
                7.2.1 Integrated Software 
                7.2.2 Standalone Software
8. Global Behavioral Health Software Market, By Delivery Model Historical Analysis and Forecast 2020-2027 (USD Million)
        8.1. Subscription Models
        8.2. Ownership Models
9. Global Behavioral Health Software Market, By Functionality Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1. Clinical Functionality
                9.1.1 Electronic Health Records (EHR) 
                9.1.2 Clinical Decision Support (CDS) 
                9.1.3 Care Plans/Health Management 
                9.1.4 E-Prescribing 
                9.1.5 Telehealth
        9.2. Administrative Functionality
                9.2.1 Patient/Client Scheduling 
                9.2.2 Document/Image Management 
                9.2.3 Case Management 
                9.2.4 Business Intelligence (BI) 
                9.2.5 Workforce Management
        9.3. Financial Functionality
                9.3.1 Revenue Cycle Management 
                9.3.2 Managed Care 
                9.3.3 Accounts Payable/General Ledger 
                9.3.4 Payroll
10. Global Behavioral Health Software Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
        10.1. Providers         
                  10.1.1 Community Clinics 
                  10.1.2 Hospitals 
                  10.1.3 Private Practices 
        10.2. Payers 
        10.3. Patients    
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
        16.1. CERNER CORPORATION    
                   16.1.1. Company Overview
                   16.1.2. Product Portfolio
                   16.1.3. SWOT Analysis
                   16.1.4. Financial Overview
                   16.1.5. Strategic Overview
        16.2. EPIC SYSTEMS  
                   16.2.1. Company Overview
                   16.2.2. Product Portfolio
                   16.2.3. SWOT Analysis
                   16.2.4. Financial Overview
                   16.2.5. Strategic Overview
        16.3. NETSMART TECHNOLOGIES
                   16.3.1. Company Overview
                   16.3.2. Product Portfolio
                   16.3.3. SWOT Analysis
                   16.3.4. Financial Overview
                   16.3.5. Strategic Overview
        16.4. NEXTGEN HEALTHCARE
                   16.4.1. Company Overview
                   16.4.2. Product Portfolio
                   16.4.3. SWOT Analysis
                   16.4.4. Financial Overview
                   16.4.5. Strategic Overview
        16.5. ALLSCRIPTS  
                   16.5.1. Company Overview
                   16.5.2. Product Portfolio
                   16.5.3. SWOT Analysis
                   16.5.4. Financial Overview
                   16.5.5. Strategic Overview
        16.6. CUREMD
                   16.6.1. Company Overview
                   16.6.2. Product Portfolio
                   16.6.3. SWOT Analysis
                   16.6.4. Financial Overview
                   16.6.5. Strategic Overview
        16.7. MEDIWARE
                   16.7.1. Company Overview
                   16.7.2. Product Portfolio
                   16.7.3. SWOT Analysis
                   16.7.4. Financial Overview
                   16.7.5. Strategic Overview
        16.8. KAREO
                   16.8.1. Company Overview
                   16.8.2. Product Portfolio
                   16.8.3. SWOT Analysis
                   16.8.4. Financial Overview
                   16.8.5. Strategic Overview
         16.9. EMIS HEALTH
                   16.9.1. Company Overview
                   16.9.2. Product Portfolio
                   16.9.3. SWOT Analysis
                   16.9.4. Financial Overview
                   16.9.5. Strategic Overview
         16.10. THE ECHO GROUP
                   16.10.1. Company Overview
                   16.10.2. Product Portfolio
                   16.10.3. SWOT Analysis
                   16.10.4. Financial Overview
                   16.10.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures